VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded up 76.5% on Thursday . The company traded as high as C$0.16 and last traded at C$0.15. 3,992,349 shares were traded during mid-day trading, an increase of 1,549% from the average session volume of 242,055 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Performance
The stock has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The business has a 50 day moving average price of C$0.10 and a two-hundred day moving average price of C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Earnings Per Share Calculator: How to Calculate EPS
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What is the NASDAQ Stock Exchange?
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Overbought Stocks Explained: Should You Trade Them?
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
